https://vettapharma.com/pharmaceutical-news/fda-grants-priority-review-for-zyduss-saroglitazar-in-primary-biliary-cholangitis-treatment/ 2026-05-29T07:43:37Z VETTAPHARMA en FDA Grants Priority Review for Zydus's Saroglitazar in Primary Biliary Cholangitis Treatment 2026-05-29T12:00:00Z Blog https://vettapharma.com/pharmaceutical-news/daiichi-sankyo-asco-oncology-updates-strengthen-adc-portfolio-expansion-across-multiple-cancers/ 2026-05-29T07:48:35Z VETTAPHARMA en Daiichi Sankyo ASCO oncology updates strengthen ADC portfolio expansion across multiple cancers 2026-05-29T12:00:00Z Blog https://vettapharma.com/pharmaceutical-news/cvs-restores-zepbound-coverage-as-lilly-expands-obesity-market-access-significantly/ 2026-05-29T08:11:31Z VETTAPHARMA en CVS restores Zepbound coverage as Lilly expands obesity market access significantly 2026-05-29T12:00:00Z Blog https://vettapharma.com/featured-scientific-stories/xpro1595-phase-ii-trial-tackling-neuroinflammation-in-alzheimers/ 2026-05-29T11:28:47Z VETTAPHARMA en XPro1595 Phase II Trial: Tackling Neuroinflammation in Alzheimer’s 2026-05-29T11:28:44Z Blog https://vettapharma.com/pharmaceutical-news/fda-approves-astrazenecas-imfinzi-for-high-risk-nmibc-key-insights/ 2026-05-29T07:02:39Z VETTAPHARMA en FDA Approves AstraZeneca's Imfinzi for High-Risk NMIBC: Key Insights 2026-05-29T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/who-prioritizes-maftivimab-for-bundibugyo-ebola-trials/ 2026-05-29T07:14:34Z VETTAPHARMA en WHO Prioritizes Maftivimab for Bundibugyo Ebola Trials 2026-05-29T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/gsks-bepirovirsen-achieves-unprecedented-cure-rates-in-hbv-patients/ 2026-05-29T07:20:12Z VETTAPHARMA en GSK's Bepirovirsen Achieves Unprecedented Cure Rates in HBV Patients 2026-05-29T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/global-pharma-leaders-urge-japan-investment-reforms-amid-life-sciences-competitiveness-concerns/ 2026-05-29T08:01:37Z VETTAPHARMA en Global pharma leaders urge Japan investment reforms amid life sciences competitiveness concerns 2026-05-29T07:55:24Z Blog